Inactive Instrument
PREDILIFE Share Price Euronext Paris
Stocks
ALPRE
FR0010169920
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - | - |
|
| 29/06 | Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 09/02 | Intégrance Launches Preventive Health Program for Employees |  |
| Market Cap | 41.44L 47.29L 47.29L 38.47L 35.35L 66.61L 46Cr 67.59L 4.58Cr 1.79Cr 22Cr 1.78Cr 1.74Cr 77Cr | P/E 2024 |
-3.18x | P/E 2025 | -3.01x |
|---|---|---|---|---|---|
| Enterprise Value | 89.21L 1.02Cr 1.02Cr 82.82L 76.1L 1.43Cr 98Cr 1.46Cr 9.87Cr 3.86Cr 48Cr 3.82Cr 3.74Cr 166.07Cr | EV / Sales 2024 |
34.5x | EV / Sales 2025 | 19.3x |
| Free-Float |
48.75% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Ragusa
CEO | Chief Executive Officer | 56 | 01/01/2004 |
Émilien Gauthier
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2007 |
Marion Renelier
LAW | General Counsel | - | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Stéphane Ragusa
CHM | Chairman | 56 | 01/01/2004 |
Charles Vilgrain
BRD | Director/Board Member | 46 | 01/01/2018 |
Antoine Bricard
BRD | Director/Board Member | 58 | 01/01/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.95% | -.--% | +116.94% | +10.40% | 2TCr | |
| -2.55% | +2.45% | +151.89% | +102.97% | 475.01Cr | |
| -2.79% | +2.43% | +112.90% | +171.66% | 361.38Cr | |
| -5.66% | +31.55% | +107.63% | -32.59% | 244.68Cr | |
| +2.01% | +3.82% | -26.08% | -35.34% | 208.33Cr | |
| -1.97% | +30.59% | +196.31% | +255.41% | 199.1Cr | |
| 0.00% | +9.06% | +198.32% | -43.20% | 104.73Cr | |
| -1.10% | -2.71% | -13.50% | +25.12% | 84Cr | |
| -0.14% | +1.86% | -36.72% | -14.16% | 49Cr | |
| Average | -1.25% | +8.34% | +89.74% | +48.92% | 414.33Cr | |
| Weighted average by Cap. | -0.48% | +5.43% | +113.96% | +44.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 5L 6L 6L 5L 4L 8L 5.43Cr 8L 54.54L 21.35L 2.66Cr 21.13L 20.67L 9.18Cr | 8L 10L 10L 8L 7L 13.44L 9.2Cr 13.63L 92.43L 36.18L 4.5Cr 35.81L 35.04L 16Cr |
| Net income | -42.65L -48.67L -48.67L -39.59L -36.38L -68.55L -47Cr -69.56L -4.72Cr -1.85Cr -23Cr -1.83Cr -1.79Cr -79Cr | -39.34L -44.9L -44.9L -36.53L -33.56L -63.25L -43Cr -64.18L -4.35Cr -1.7Cr -21Cr -1.69Cr -1.65Cr -73Cr |
| Net Debt | 35.38L 40.38L 40.38L 32.85L 30.19L 56.88L 39Cr 57.72L 3.91Cr 1.53Cr 19Cr 1.52Cr 1.48Cr 66Cr | 47.78L 54.53L 54.53L 44.35L 40.76L 76.8L 53Cr 77.93L 5.28Cr 2.07Cr 26Cr 2.05Cr 2Cr 89Cr |
Employees
-
- Stock Market
- Stocks
- ALPRE Stock
- ALPRE Stock
Select your edition
All financial news and data tailored to specific country editions
